| Elizabeth Di Zenzo, | |
|
1835 W Central Rd, Arlington Heights, IL 60005-2410 | |
| (847) 392-2812 | |
| Not Available |
| Full Name | Elizabeth Di Zenzo |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1835 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770143778 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | 32620 (California) | Primary |
| Provider Name | Orthopaedic And Neurological Rehab Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1225496540 PECOS PAC ID: 6507159126 Enrollment ID: O20160720000431 |
News Archive
Patients having outpatient gallbladder surgery whose experience was coordinated by a physician anesthesiologist through the Perioperative Surgical Home (PSH) model of care had shorter wait times before surgery, recovered more quickly after the procedure and were less likely to require care for complications, according to two studies presented at the ANESTHESIOLOGY 2015 annual meeting.
Oregon's top insurance regulator is joining the Health and Human Services Department to help implement insurance exchanges. Oregon Insurance Administrator Teresa Miller will start at HHS next month, according to a department email. She'll be a senior adviser on exchanges, working with state governments to get the new insurance marketplaces off the ground.
Increasing puromycin-sensitive aminopeptidase, the most abundant brain peptidase in mammals, slowed the damaging accumulation of tau proteins that are toxic to nerve cells and eventually lead to the neurofibrillary tangles, a major pathological hallmark of Alzheimer's disease and other forms of dementia, according to a study published online in the journal, Human Molecular Genetics.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
› Verified 4 days ago
| Provider Name | New Life Physical Therapy Services Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1285160788 PECOS PAC ID: 7214207125 Enrollment ID: O20170726001800 |
News Archive
Patients having outpatient gallbladder surgery whose experience was coordinated by a physician anesthesiologist through the Perioperative Surgical Home (PSH) model of care had shorter wait times before surgery, recovered more quickly after the procedure and were less likely to require care for complications, according to two studies presented at the ANESTHESIOLOGY 2015 annual meeting.
Oregon's top insurance regulator is joining the Health and Human Services Department to help implement insurance exchanges. Oregon Insurance Administrator Teresa Miller will start at HHS next month, according to a department email. She'll be a senior adviser on exchanges, working with state governments to get the new insurance marketplaces off the ground.
Increasing puromycin-sensitive aminopeptidase, the most abundant brain peptidase in mammals, slowed the damaging accumulation of tau proteins that are toxic to nerve cells and eventually lead to the neurofibrillary tangles, a major pathological hallmark of Alzheimer's disease and other forms of dementia, according to a study published online in the journal, Human Molecular Genetics.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Di Zenzo, 2450 N Central Ave, Chicago, IL 60639-1316 Ph: () - | Elizabeth Di Zenzo, 1835 W Central Rd, Arlington Heights, IL 60005-2410 Ph: (847) 392-2812 |
News Archive
Patients having outpatient gallbladder surgery whose experience was coordinated by a physician anesthesiologist through the Perioperative Surgical Home (PSH) model of care had shorter wait times before surgery, recovered more quickly after the procedure and were less likely to require care for complications, according to two studies presented at the ANESTHESIOLOGY 2015 annual meeting.
Oregon's top insurance regulator is joining the Health and Human Services Department to help implement insurance exchanges. Oregon Insurance Administrator Teresa Miller will start at HHS next month, according to a department email. She'll be a senior adviser on exchanges, working with state governments to get the new insurance marketplaces off the ground.
Increasing puromycin-sensitive aminopeptidase, the most abundant brain peptidase in mammals, slowed the damaging accumulation of tau proteins that are toxic to nerve cells and eventually lead to the neurofibrillary tangles, a major pathological hallmark of Alzheimer's disease and other forms of dementia, according to a study published online in the journal, Human Molecular Genetics.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
› Verified 4 days ago
Mrs. Megan Brazas, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 W Maude Ave, Arlington Heights, IL 60004 Phone: 630-329-2389 | |
Mrs. Gloria S Vosburgh, M. ED. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E Ivy Ln, Arlington Heights, IL 60004 Phone: 847-253-9470 | |
Christine Anne Loprest, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2211 N Burke Dr, Arlington Heights, IL 60004 Phone: 847-398-4275 | |
Judith Ildiko Jokay, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1315 E Miner St, Arlington Heights, IL 60004 Phone: 847-398-4297 | |
Miss Aimee Rose Leblanc, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Dunton Ave, Arlington Heights, IL 60005 Phone: 847-758-7958 | |
Amy Leigh Sarna, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 S Goebbert Rd, Arlington Heights, IL 60005 Phone: 847-718-4965 | |
Julie M. Wyss, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Central Rd, Arlington Heights, IL 60005 Phone: 847-506-3482 |